GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
iSERA Lifesciences Ltd

iSERA Lifesciences Reports Q2 FY27 Net Loss of INR (13.11) Lakhs

RESULTS ▼ Concern Flagged HIGH RISK
📅 Filed on BSE: 04 Nov 2026, 05:36 PM IST  ·  BSE ID: bfb7ee3c-b79d-4f4c-9eaf-e9faaea607fd
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board approved its financial results, showing a net loss of INR (13.11) Lakhs for the quarter.
🤖 AI Summary
  • iSERA Lifesciences Board approved Q2 FY27 standalone unaudited financial results.
  • Company reported a net loss of INR (13.11) Lakhs for the quarter ended September 30, 2026.
  • Total expenses for Q2 FY27 stood at INR 20.99 Lakhs.
  • The Board meeting for approval took place on November 4, 2026.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Net Profit for the period (Q2 FY27)
INR (13.11) Lakhs
Not comparable — limited prior period data.
Net Profit for the previous quarter (Q1 FY27)
INR (33.62) Lakhs
Total Expenses (Q2 FY27)
INR 20.99 Lakhs
Reserves and Surplus (as of 30 Sep 2026)
INR (52.92) Lakhs
Equity Share Capital (as of 30 Sep 2026)
INR 840.50 Lakhs
Earnings per Equity Share (Basic & Diluted, Q2 FY27)
INR (0.62)
🏢 How This Affects the Company
💰
Financial Impact
The company recorded a net loss of INR (13.11) Lakhs for Q2 FY27, following a loss of INR (33.62) Lakhs in Q1 FY27. Total liabilities as of September 30, 2026, were INR 802.59 Lakhs.
⚠️
Risk Impact
The ongoing net losses indicate operational challenges, impacting the company's financial stability as reflected in negative reserves and surplus of INR (52.92) Lakhs.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this filing.
👤
Who Is Affected
All shareholders are affected by the company's reported net losses and the status of its reserves and surplus, which impacts the intrinsic value of their holdings.
🔍
Management Signal
The approval of unaudited results indicates management's adherence to regulatory disclosure requirements for financial performance.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Q3 FY27 financial results — check for any change in loss trend.
Operational updates — monitor business development announcements.
Future balance sheet disclosures — assess changes in reserves and surplus.
HIGH RISK Persistent net losses and negative reserves indicate significant financial challenges.
💡 Investor Takeaway
iSERA Lifesciences reported a net loss of INR (13.11) Lakhs for Q2 FY27, following a net loss of INR (33.62) Lakhs in Q1 FY27. Total expenses for the quarter were INR 20.99 Lakhs. Reserves and Surplus are negative at INR (52.92) Lakhs as of September 30, 2026.
⚖️ Strengths & Concerns

⚠️ Concerns

  • The company reported a net loss of INR (13.11) Lakhs for Q2 FY27 and INR (33.62) Lakhs for Q1 FY27.
  • Reserves and Surplus showed a negative balance of INR (52.92) Lakhs as of September 30, 2026.
📅 Company Track Record
iSERA Lifesciences (formerly Covidh Technologies Limited) consistently reported net losses in recent filings. Q2 FY27 net loss of INR (13.11) Lakhs follows Q1 FY27 net loss of INR (33.62) Lakhs, and a previous Q2 FY27 net loss of INR (13.11) Lakhs was also reported on November 4, 2026, and a prior report indicated no operational revenue.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was iSERA Lifesciences' net profit for Q2 FY27?
iSERA Lifesciences reported a net loss of INR (13.11) Lakhs for the quarter ended September 30, 2026 (Q2 FY27).
What were the total expenses for iSERA Lifesciences in Q2 FY27?
Total expenses for iSERA Lifesciences in Q2 FY27 amounted to INR 20.99 Lakhs.
What was the company's Reserves and Surplus position as of September 30, 2026?
As of September 30, 2026, iSERA Lifesciences had a negative Reserves and Surplus balance of INR (52.92) Lakhs.
What was the Earnings per Share (EPS) for iSERA Lifesciences in Q2 FY27?
The Basic and Diluted Earnings per Equity Share for iSERA Lifesciences in Q2 FY27 was INR (0.62).

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.